Evidence map›Paper›PMID 35601687›Full record

ArticleNeurobiology of stress2022

Mineralocorticoid receptor and glucocorticoid receptor work alone and together in cell-type-specific manner: Implications for resilience prediction and targeted therapy.

Nikolaos P Daskalakis, Onno C Meijer, E Ron de Kloet

Abstract read
In one paragraph

Article in Neurobiology of stress, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Validity of mental and physical stress models.Neuroscience and biobehavioral reviews · 2024
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nikolaos P DaskalakisDepartment of Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA, USA.
Onno C MeijerDivision of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, the Netherlands.
E Ron de KloetDivision of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, the Netherlands.

Funding

Integrating neuroimaging and brain gene expression for functional characterization of psychiatric GWASR21MH121909 · NIMH · MCLEAN HOSPITAL · PI DASKALAKIS, NIKOLAOS · 2020 to 2020
$451k
NIMH NIH HHS R21 MH121909
6 · The paper itself

Abstract

'You can't roll the clock back and reverse the effects of experiences' Bruce McEwen used to say when explaining how allostasis labels the adaptive process. Here we will for once roll the clock back to the times that the science of the glucocorticoid hormone was honored with a Nobel prize and highlight the discovery of their receptors in the hippocampus as inroad to its current status as master regulator in control of stress coping and adaptation. Glucocorticoids operate in concert with numerous neurotransmitters, neuropeptides, and other hormones with the aim to facilitate processing of information in the neurocircuitry of stress, from anticipation and perception of a novel experience to behavioral adaptation and memory storage. This action, exerted by the glucocorticoids, is guided by two complementary receptor systems, mineralocorticoid receptors (MR) and glucocorticoid receptors (GR), that need to be balanced for a healthy stress response pattern. Here we discuss the cellular, neuroendocrine, and behavioral studies underlying the MR:GR balance concept, highlight the relevance of hypothalamic-pituitary-adrenal (HPA) -axis patterns and note the limited understanding yet of sexual dimorphism in glucocorticoid actions. We conclude with the prospect that (i) genetically and epigenetically regulated receptor variants dictate cell-type-specific transcriptome signatures of stress-related neuropsychiatric symptoms and (ii) selective receptor modulators are becoming available for more targeted treatment. These two new developments may help to 'restart the clock' with the prospect to support resilience.

Indexed as

ACTH, Adrenocorticotropic hormoneAllostatic loadBrainCell typeCortisolCRH, Corticotrophin-releasinghormoneEarly life programmingGlucocorticoidGlucocorticoid receptorGREs, Glucocorticoid response elementsGR, Glucocorticoid receptorHippocampusHPA-axis, Hypothalamic-pituitary-adrenal-axisHypothalamic-pituitary-adrenal-axisMineralocorticoid receptorMR, Mineralocorticoid receptorRegulationResilienceStress coping and adaptationStress responseVulnerability

Identifiers

PMID35601687
PMCPMC9118500

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.